Celon Pharma S.A. (CLN)
GPW
Real-time Data
07:00 AM
Day's Range
22.2052 wk Range
18.50Overview - CLN - Celon Pharma S.A.
Key Statistics
Valuation
Enterprise Value
1.26B
P/E (Trailing)
‪11.13‬
P/E (Forward)
‪14.12‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪3.45‬
Price / Book
‪2.30‬
EV / EBITDA
‪65.87‬
Profitability
Gross Margin
‪70.66%‬
Profit Margin
‪42.57%‬
Operating Margin
‪-9.74%‬
Return on Assets
‪-1.27%‬
Return on Equity
‪22.84%‬
Ownership
Shares Outstanding
53.85M
Float
23.82M
Held by Insiders
‪55.69%‬
Held by Institutions
‪18.36%‬
Price stats
Beta
‪0.62‬
50-Day Avg
‪20.39‬
200-Day Avg
‪20.97‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪PLN 20.44‬Market Cap - CLN - Celon Pharma S.A.
Peers - CLN - Celon Pharma S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on GPW.
- CLNGPWCelon Pharma S.A.879.39MMarket Cap-0.66%52-week change11.13P/E (Trailing)‪42.57%‬Profit Margin
- MILGPWBank Millennium S.A.25.59BMarket Cap+24.91%52-week change18.43P/E (Trailing)‪20.47%‬Profit Margin
- CTXGPWCaptor Therapeutics S.A.449.67MMarket Cap+43.24%52-week change-9.33P/E (Trailing)‪68.99%‬Profit Margin
- KPLGPWKino Polska TV S.A.386.51MMarket Cap+5.64%52-week change4.80P/E (Trailing)‪23.95%‬Profit Margin
- CLCGPWColumbus Capital S.A.236.23MMarket Cap-96.80%52-week change2.07P/E (Trailing)‪45.35%‬Profit Margin
- EAHGPWEsotiq & Henderson S.A.71.36MMarket Cap-3.86%52-week change18.43P/E (Trailing)‪1.71%‬Profit Margin
- PBFGPWPbs Finanse S.A.11.81MMarket Cap+47.00%52-week change113.00P/E (Trailing)‪2.58%‬Profit Margin
Profile Summary - CLN - Celon Pharma S.A.
About
Celon Pharma S.A. is a research-oriented biopharmaceutical company based in Poland, known for its focus on developing innovative therapies to address unmet medical needs. The company's primary purpose is to discover and commercialize novel treatments across various therapeutic areas, including oncology, neurology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
